# Valery "Z" Grdzelishvili

> academic, researcher, professor of biological science

**Wikidata**: [Q109981230](https://www.wikidata.org/wiki/Q109981230)  
**Source**: https://4ort.xyz/entity/valery-z-grdzelishvili


## References

1. [University of North Carolina at Charlotte](https://pages.charlotte.edu/valery-grdzelishvili/)
2. [ORCID iD](https://orcid.org/0000-0001-8715-3840)
3. [Google Scholar](https://scholar.google.com/citations?hl=en&user=md3R3DEAAAAJ)
4. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus
5. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma
6. Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma.
7. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
8. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling
9. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma
10. Therapeutic Efficacy of MUC1-Specific Cytotoxic T Lymphocytes and CD137 Co-Stimulation in a Spontaneous Breast Cancer Model
11. Cell cycle arrest in G2/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via inhibition of antiviral gene expression
12. Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
13. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus
14. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
15. Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1
16. An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells
17. Understanding and altering cell tropism of vesicular stomatitis virus
18. Detecting protein–protein interactions in vesicular stomatitis virus using a cytoplasmic yeast two hybrid system
19. RIG‐I mediates nonsegmented negative‐sense RNA virus‐induced inflammatory immune responses of primary human astrocytes
20. Sequence-function analysis of the Sendai virus L protein domain VI.
21. Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses
22. Cellular proteins associated with the interior and exterior of vesicular stomatitis virus virions
23. Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach.
24. Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation
25. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation
26. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells
27. Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
28. Evolution of oncolytic viruses
29. Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus
30. Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin
31. Identification of Sendai Virus L Protein Amino Acid Residues Affecting Viral mRNA Cap Methylation
32. Mutual Interference between Genomic RNA Replication and Subgenomic mRNA Transcription in Brome Mosaic Virus
33. Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus
34. [University of North Carolina at Charlotte](https://sds.charlotte.edu/directory/valery-grdzelishvili/)